Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pressure BioSciences Inc. (PBIO) had Revenue of $1.98M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$1.98M
Net Income	$-35.20M
Cost of Goods Sold	$1.18M
Gross Profit	$0.80M
Operating Expenses	$11.48M
Operating Income	$-9.50M
Non-Operating Income/Expense	$-19.81M
Pre-Tax Income	$-29.31M
Normalized Pre-Tax Income	$-29.31M
Income after Taxes	$-29.31M
Income from Continuous Operations	$-29.31M
Consolidated Net Income/Loss	$-29.31M
Normalized Income after Taxes	$-29.31M
EBIT	$-9.50M
EBITDA	$-6.88M
Weighted-Average Shares Outstanding (Basic)	23.34M
Weighted-Average Shares Outstanding (Diluted)	23.34M
Earnings per Share (EPS) (Basic)	$-1.51
Earnings per Share (EPS) (Diluted)	$-1.51
Balance Sheet Financials
Current Assets	$0.76M
Property, Plant, and Equipment	$0.08M
Long-Term Assets	$0.29M
Total Assets	$1.05M
Current Liabilities	$33.58M
Long-Term Debt	$0.16M
Long-Term Liabilities	$0.23M
Total Liabilities	$33.80M
Common Equity	$-32.75M
Tangible Shareholders Equity	$-32.75M
Shareholders Equity	$-32.75M
Common Shares Outstanding	35.37M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-3.19M
Cash Flow from Investing Activities	$-0.01M
Cash Flow from Financial Activities	$3.27M
Beginning Cash	$0.00M
End Cash	$0.08M
Increase/Decrease in Cash	$0.08M
Stock-Based Compensation	$2.64M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.01
Debt to Equity Ratio	-0.69
Gross Margin	40.43%
Operating Margin	-480.51%
EBIT Margin	-480.51%
EBITDA Margin	-348.06%
Pre-Tax Profit Margin	-1482.19%
Profit Margin	-1779.91%
Free Cash Flow	$-3.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.88
Inventory Turnover	3.86
Receiveable Turnover	13.08
Days Sales in Receivables	27.91
Return on Equity	89.50%
Return on Tangible Equity	89.50%
Return on Assets	-2792.70%
Return on Investments	89.94%
Book Value Per Share	$-0.93
Free Cash Flow per Share	$-0.14
Operating Cash Flow per Share	$-0.14

Data from Zacks Investment Research, Inc.